PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ZBH vs. SNN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ZBH and SNN is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

ZBH vs. SNN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zimmer Biomet Holdings, Inc. (ZBH) and Smith & Nephew plc (SNN). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
0.05%
-10.47%
ZBH
SNN

Key characteristics

Sharpe Ratio

ZBH:

-0.44

SNN:

-0.20

Sortino Ratio

ZBH:

-0.48

SNN:

-0.09

Omega Ratio

ZBH:

0.94

SNN:

0.99

Calmar Ratio

ZBH:

-0.24

SNN:

-0.10

Martin Ratio

ZBH:

-0.64

SNN:

-0.43

Ulcer Index

ZBH:

15.01%

SNN:

11.71%

Daily Std Dev

ZBH:

21.72%

SNN:

25.90%

Max Drawdown

ZBH:

-65.03%

SNN:

-55.20%

Current Drawdown

ZBH:

-34.87%

SNN:

-44.44%

Fundamentals

Market Cap

ZBH:

$21.20B

SNN:

$11.03B

EPS

ZBH:

$5.24

SNN:

$0.71

PE Ratio

ZBH:

20.33

SNN:

35.62

PEG Ratio

ZBH:

1.40

SNN:

0.42

Total Revenue (TTM)

ZBH:

$5.66B

SNN:

$2.83B

Gross Profit (TTM)

ZBH:

$3.63B

SNN:

$1.97B

EBITDA (TTM)

ZBH:

$1.81B

SNN:

$520.00M

Returns By Period

In the year-to-date period, ZBH achieves a 3.72% return, which is significantly higher than SNN's 2.89% return. Over the past 10 years, ZBH has outperformed SNN with an annualized return of 0.45%, while SNN has yielded a comparatively lower -1.23% annualized return.


ZBH

YTD

3.72%

1M

2.51%

6M

-0.25%

1Y

-10.42%

5Y*

-4.92%

10Y*

0.45%

SNN

YTD

2.89%

1M

2.55%

6M

-9.93%

1Y

-7.62%

5Y*

-10.49%

10Y*

-1.23%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ZBH vs. SNN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZBH
The Risk-Adjusted Performance Rank of ZBH is 2525
Overall Rank
The Sharpe Ratio Rank of ZBH is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of ZBH is 2020
Sortino Ratio Rank
The Omega Ratio Rank of ZBH is 2020
Omega Ratio Rank
The Calmar Ratio Rank of ZBH is 3131
Calmar Ratio Rank
The Martin Ratio Rank of ZBH is 3333
Martin Ratio Rank

SNN
The Risk-Adjusted Performance Rank of SNN is 3434
Overall Rank
The Sharpe Ratio Rank of SNN is 3636
Sharpe Ratio Rank
The Sortino Ratio Rank of SNN is 2929
Sortino Ratio Rank
The Omega Ratio Rank of SNN is 2929
Omega Ratio Rank
The Calmar Ratio Rank of SNN is 4040
Calmar Ratio Rank
The Martin Ratio Rank of SNN is 3737
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ZBH vs. SNN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Zimmer Biomet Holdings, Inc. (ZBH) and Smith & Nephew plc (SNN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ZBH, currently valued at -0.44, compared to the broader market-2.000.002.004.00-0.44-0.20
The chart of Sortino ratio for ZBH, currently valued at -0.48, compared to the broader market-4.00-2.000.002.004.006.00-0.48-0.09
The chart of Omega ratio for ZBH, currently valued at 0.94, compared to the broader market0.501.001.502.000.940.99
The chart of Calmar ratio for ZBH, currently valued at -0.24, compared to the broader market0.002.004.006.00-0.24-0.10
The chart of Martin ratio for ZBH, currently valued at -0.64, compared to the broader market-10.000.0010.0020.0030.00-0.64-0.43
ZBH
SNN

The current ZBH Sharpe Ratio is -0.44, which is lower than the SNN Sharpe Ratio of -0.20. The chart below compares the historical Sharpe Ratios of ZBH and SNN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
-0.44
-0.20
ZBH
SNN

Dividends

ZBH vs. SNN - Dividend Comparison

ZBH's dividend yield for the trailing twelve months is around 0.88%, less than SNN's 2.97% yield.


TTM20242023202220212020201920182017201620152014
ZBH
Zimmer Biomet Holdings, Inc.
0.88%0.91%0.79%0.75%0.76%0.62%0.64%0.93%0.80%0.93%0.86%0.78%
SNN
Smith & Nephew plc
2.97%3.05%2.75%2.79%2.17%1.78%1.51%1.96%1.76%2.08%1.71%1.52%

Drawdowns

ZBH vs. SNN - Drawdown Comparison

The maximum ZBH drawdown since its inception was -65.03%, which is greater than SNN's maximum drawdown of -55.20%. Use the drawdown chart below to compare losses from any high point for ZBH and SNN. For additional features, visit the drawdowns tool.


-45.00%-40.00%-35.00%-30.00%AugustSeptemberOctoberNovemberDecember2025
-34.87%
-44.44%
ZBH
SNN

Volatility

ZBH vs. SNN - Volatility Comparison

Zimmer Biomet Holdings, Inc. (ZBH) and Smith & Nephew plc (SNN) have volatilities of 5.73% and 5.72%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%16.00%AugustSeptemberOctoberNovemberDecember2025
5.73%
5.72%
ZBH
SNN

Financials

ZBH vs. SNN - Financials Comparison

This section allows you to compare key financial metrics between Zimmer Biomet Holdings, Inc. and Smith & Nephew plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab